← All organizations

Panoptes Pharma

For profitWebsite ↗

Also known as: Panoptes Pharma | Panoptes Pharma GmbH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 15, 2018

Acquired by Eyegate Pharmaceuticals, Inc. on Dec 21, 2020

Timeline

2010s

Jun 1, 2013
Panoptes Pharma— Founded

2020s

Dec 21, 2020
Eyegate Pharmaceuticals, Inc.— Acquired By

Drugs by trial phase (1 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

pp-001

Indications

Studied for

Recent trials (3)

NCT03769454Lead sponsorPhase 1Nov 15, 2018
NCT03634475Study directorPhase 1/Phase 2Jan 31, 2017
NCT03634475Lead sponsorPhase 1/Phase 2Jan 31, 2017

Details

Founded: Vienna, AT Jun 1, 2013
Last known activity: Nov 15, 2018